awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38987211-45817C17-21EC-4E4E-B558-D286E95045C5
Q38987211-45817C17-21EC-4E4E-B558-D286E95045C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38987211-45817C17-21EC-4E4E-B558-D286E95045C5
Impact of Shed/Soluble targets on the PK/PD of approved therapeutic monoclonal antibodies.
P2860
Q38987211-45817C17-21EC-4E4E-B558-D286E95045C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38987211-45817C17-21EC-4E4E-B558-D286E95045C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2fdff584ead3213813c9f7c7ab68bf854e7a261b
P2860
Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response